Multiple Sourcing Framework Contracts to Speed up the Development of and Access to Innovative Medical Countermeasures: Next-Generation Influenza Vaccines
Awarded
The competition has ended and a winner has been selected.
Statistikk og markedsundersøkelser
The Health and Digital Executive Agency (HaDEA) in Belgium has entered into multiple sourcing framework contracts with SSI, BAVARIAN NORDIC, NIVI Development P/S, ETHRIS, VISMEDERI SRL, ECRAID, EVO, IDT, SANOFI R&D VACCINS, and SVA for research and development services. The contracts aim to accelerate the development of next-generation influenza vaccines, focusing on rapidly scalable manufacturing platforms, novel administration routes, mucosal immunity, targeting pandemic influenza A viruses, and broad protection across influenza subtypes or alpha-influenza viruses, with an estimated maximum total value of 225 million EUR over 98 months. The procurement was implemented through a competitive development in phases as a Pre-Commercial Procurement.
Result
- Winners
- BAVARIAN NORDIC A/S
- ECRAID
- ETHRIS
- EVO
- IDT
- NIVI Development P/S
- SANOFI R&D VACCINS
- STATENS SERUM INSTITUT
- SVA
- VISMEDERI SRL
- Number of bids
- 8
- Contract value
- Not stated
- Maximum framework agreement value
- Up to €225,000,000
About the bid
- Contact phone
- +32 2 299 11 11
- Contact email
- hadea-procurement@ec.europa.eu
- Address
- COV2, Place Charles Rogier 16, B-1210 Brussels
This call for tenders aims to speed up the development of next generation influenza vaccines that could be produced in rapidly scalable manufacturing platforms (e.g. nucleic acid approaches and/or production in scalable eukaryotic or bacterial cell culture, in plants or via in vitro transcription), could support products utilising novel administration routes (e.g. nasal, oral or through microneedle patches), confer mucosal immunity, target potentially pandemic influenza A viruses or could be rapidly adapted to pandemic influenza A viruses, which are protective across influenza subtypes or across alpha-influenza viruses, and/or possess intrinsic immunogenicity without the addition of adjuvants. The call will be implemented via a competitive development in phases as foreseen under Pre-Commercial Procurement.
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Description
Please consult the procurement documents.
Description
Please consult the procurement documents.
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
- Title
- Multiple Sourcing Framework Contracts to Speed up the Development of and Access to Innovative Medical Countermeasures: Next-Generation Influenza Vaccines
- Type
- Main code
- Supplemental codes
- Estimated value
- €225,000,000.00
- Duration
- 98 months